RNA-dependent conversion of phosphoserine forms selenocysteine in eukaryotes and archaea
- PMID: 17142313
- PMCID: PMC1748153
- DOI: 10.1073/pnas.0609703104
RNA-dependent conversion of phosphoserine forms selenocysteine in eukaryotes and archaea
Abstract
The trace element selenium is found in proteins as selenocysteine (Sec), the 21st amino acid to participate in ribosome-mediated translation. The substrate for ribosomal protein synthesis is selenocysteinyl-tRNA(Sec). Its biosynthesis from seryl-tRNA(Sec) has been established for bacteria, but the mechanism of conversion from Ser-tRNA(Sec) remained unresolved for archaea and eukarya. Here, we provide evidence for a different route present in these domains of life that requires the tRNA(Sec)-dependent conversion of O-phosphoserine (Sep) to Sec. In this two-step pathway, O-phosphoseryl-tRNA(Sec) kinase (PSTK) converts Ser-tRNA(Sec) to Sep-tRNA(Sec). This misacylated tRNA is the obligatory precursor for a Sep-tRNA:Sec-tRNA synthase (SepSecS); this protein was previously annotated as SLA/LP. The human and archaeal SepSecS genes complement in vivo an Escherichia coli Sec synthase (SelA) deletion strain. Furthermore, purified recombinant SepSecS converts Sep-tRNA(Sec) into Sec-tRNA(Sec) in vitro in the presence of sodium selenite and purified recombinant E. coli selenophosphate synthetase (SelD). Phylogenetic arguments suggest that Sec decoding was present in the last universal common ancestor. SepSecS and PSTK coevolved with the archaeal and eukaryotic lineages, but the history of PSTK is marked by several horizontal gene transfer events, including transfer to non-Sec-decoding Cyanobacteria and fungi.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Comment in
-
Selenocysteine, soluble liver antigen/liver-pancreas, and autoimmune hepatitis.Hepatology. 2007 Jul;46(1):275-7. doi: 10.1002/hep.21807. Hepatology. 2007. PMID: 17596869 No abstract available.
Similar articles
-
Genetic analysis of selenocysteine biosynthesis in the archaeon Methanococcus maripaludis.Mol Microbiol. 2011 Jul;81(1):249-58. doi: 10.1111/j.1365-2958.2011.07690.x. Epub 2011 May 18. Mol Microbiol. 2011. PMID: 21564332 Free PMC article.
-
Structural and functional investigation of a putative archaeal selenocysteine synthase.Biochemistry. 2005 Oct 11;44(40):13315-27. doi: 10.1021/bi051110r. Biochemistry. 2005. PMID: 16201757
-
Divergence of selenocysteine tRNA recognition by archaeal and eukaryotic O-phosphoseryl-tRNASec kinase.Nucleic Acids Res. 2008 Apr;36(6):1871-80. doi: 10.1093/nar/gkn036. Epub 2008 Feb 11. Nucleic Acids Res. 2008. PMID: 18267971 Free PMC article.
-
Human SepSecS or SLA/LP: selenocysteine formation and autoimmune hepatitis.Biol Chem. 2010 Jul;391(7):771-6. doi: 10.1515/BC.2010.078. Biol Chem. 2010. PMID: 20623998 Free PMC article. Review.
-
Biosynthesis of selenocysteine, the 21st amino acid in the genetic code, and a novel pathway for cysteine biosynthesis.Adv Nutr. 2011 Mar;2(2):122-8. doi: 10.3945/an.110.000265. Epub 2011 Mar 10. Adv Nutr. 2011. PMID: 22332041 Free PMC article. Review.
Cited by
-
Overcoming Challenges with Biochemical Studies of Selenocysteine and Selenoproteins.Int J Mol Sci. 2024 Sep 20;25(18):10101. doi: 10.3390/ijms251810101. Int J Mol Sci. 2024. PMID: 39337586 Free PMC article. Review.
-
De novo missense variants in exon 9 of SEPHS1 cause a neurodevelopmental condition with developmental delay, poor growth, hypotonia, and dysmorphic features.Am J Hum Genet. 2024 Apr 4;111(4):778-790. doi: 10.1016/j.ajhg.2024.02.016. Epub 2024 Mar 25. Am J Hum Genet. 2024. PMID: 38531365 Free PMC article.
-
tRNA engineering strategies for genetic code expansion.Front Genet. 2024 Mar 7;15:1373250. doi: 10.3389/fgene.2024.1373250. eCollection 2024. Front Genet. 2024. PMID: 38516376 Free PMC article. Review.
-
Biosynthesis, Engineering, and Delivery of Selenoproteins.Int J Mol Sci. 2023 Dec 22;25(1):223. doi: 10.3390/ijms25010223. Int J Mol Sci. 2023. PMID: 38203392 Free PMC article. Review.
-
Thioredoxin Reductase and Organometallic Complexes: A Pivotal System to Tackle Multidrug Resistant Tumors?Cancers (Basel). 2023 Sep 6;15(18):4448. doi: 10.3390/cancers15184448. Cancers (Basel). 2023. PMID: 37760418 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
